ArticleJournal of robotic surgery2026
Real-time digital assistance improves surgeon efficiency and autonomy in robotic microvascular anastomosis: a pilot feasibility study.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Robotic microsurgery offers greater precision compared to manual surgical techniques and enables vascular anastomoses at submillimeter scales. This pilot study evaluated the incorporation of the Synaptix® Digital Surgery Platform, which provides a real-time system information overlay displaying essential data such as instrument status, motion scaling, and recovery details, with the Symani® Surgical System for microvascular anastomosis. Three surgeons (plastic surgery, neurosurgery, and head and neck) performed 1–2 mm synthetic vessel anastomoses using Symani alone and Symani with Synaptix. Metrics included Anastomosis Time, Teleoperation Exits, Re-Entry Time, Re-Entry Attempts, Assistant Use, and Exit Reason Match (alignment between system-logged and surgeon-identified explanations for each teleoperation exit event). Compared with Symani alone, mean Anastomosis Time was numerically shorter with Symani + Synaptix (20% reduction; 24.2 ± 7.2 vs. 19.4 ± 5.2 min), though this difference did not reach statistical significance (n = 3). Teleoperation Exits decreased by 44% (4.5 ± 0.5 vs. 2.5 ± 0.71). Re-Entry Time was reduced by 50% (0.38 ± 0.13 vs. 0.19 ± 0.01 min), and Re-Entry Attempts decreased by approximately 10%. Assistant Use decreased from 15% to 0%. Exit Reason Match was 75% when Synaptix was used with Symani compared to 26% when Symani was used without Synaptix. All surgeons reported that Synaptix improved visualization, reduced fatigue, and increased autonomy. Although performance gains varied by surgeon and vessel size, each demonstrated measurable benefit. These findings indicate that real-time digital assistance may streamline workflow, enhance performance across expertise levels, and facilitate broader adoption of robotic open microsurgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.